Given REF is incompatible with our hg38 reference sequence (N). Please double check if it's correct.
Y-630833-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000711141.1(SHOX):c.-65C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: )
Consequence
SHOX
ENST00000711141.1 5_prime_UTR
ENST00000711141.1 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.88
Genes affected
SHOX (HGNC:10853): (SHOX homeobox) This gene belongs to the paired homeobox family and is located in the pseudoautosomal region 1 (PAR1) of X and Y chromosomes. Defects in this gene are associated with idiopathic growth retardation and in the short stature phenotype of Turner syndrome patients. This gene is highly conserved across species from mammals to fish to flies. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (Cadd=11.72).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHOX_1 | NM_000451.4_1 | c.-65C>A | 5_prime_UTR_variant | 1/5 | ||||
SHOX_1 | NM_006883.2_1 | c.-65C>A | 5_prime_UTR_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHOX | ENST00000711142.1 | c.-65C>A | 5_prime_UTR_variant | 1/5 | ENSP00000518640.1 | |||||
SHOX | ENST00000711141.1 | c.-65C>A | 5_prime_UTR_variant | 1/5 | 1 | ENSP00000518639.1 | ||||
SHOX | ENST00000711145.1 | c.-65C>A | 5_prime_UTR_variant | 2/6 | 5 | ENSP00000518642.1 | ||||
SHOX | ENST00000711143.1 | c.-65C>A | 5_prime_UTR_variant | 2/6 | 5 | ENSP00000518641.1 |
Frequencies
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 19, 2023 | Variant summary: HOX c.-65C>A is located in the untranslated mRNA region upstream of the initiation codon. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 2.7e-05 in 1598724 control chromosomes (gnomAD v4). This frequency is not significantly higher than estimated for a pathogenic variant in SHOX causing Leri-Weill Dyschondrosteosis (2.7e-05 vs 0.00025), allowing no conclusion about variant significance. c.-65C>A has been reported in the literature in individuals affected with Leri-Weill Dyschondrosteosis or suspected skeletal dysplasia (Grigelioniene_2001, Scocchia_2021). These reports do not provide unequivocal conclusions about association of the variant with Leri-Weill Dyschondrosteosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 11735031, 34627339). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
SHOX-related short stature Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare | Oct 07, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
CADD
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at